APO RESEARCH · REPORT
Neurorehabilitation
Neurorehabilitation refers to a structured, multidisciplinary set of medical and therapy interventions that aim to restore, compensate for, or optimize neurological function and participation after injury or disease of the central or peripheral nervous system.
Product & engineering
Understand the product.
The research object may be an ingredient, device, preparation or care service. These supply stages have different specifications and measurement units; an ingredient identity or device name does not establish a clinical outcome.
What turns activity into demand
Qualified use at the specified treatment or instrument boundary creates purchases through protocol, utilisation and replacement. A product, clinical service and complete care episode measure different supplied objects.
The commercial boundary
For Neurorehabilitation, distinguish the supplied service or configured system from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.
Which conditions determine usable neurorehabilitation performance?
Neurorehabilitation refers to a structured, multidisciplinary set of medical and therapy interventions that aim to restore, compensate for, or optimize neurological function and participation after injury or disease of the central or peripheral nervous system. Confirm the specified composition or device function, intended use and supplied unit. Separate ingredients, finished preparations, equipment and treatment activity before comparing quantities or revenue; use the report scope rather than inferring efficacy from an illustration.
Selected research
Industry Research
Neurorehabilitation Industry Research Report 2026
Market perspective
The global Neurorehabilitation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Neurorehabilitation market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Neurorehabilitation market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Neurorehabilitation market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Neurorehabilitation include VISHEE, Beijing Bo'ai Hospital, Beijing Rehabilitation Hospital of Capital Medical University, NCC, CHIEFTAIN, Tongji Hospital, Haobro Medical Device, DIH and Sun Java, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Neurorehabilitation market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Neurorehabilitation.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neurorehabilitation Market by Company
VISHEE
Beijing Bo'ai Hospital
Beijing Rehabilitation Hospital of Capital Medical University
NCC
CHIEFTAIN
Tongji Hospital
Haobro Medical Device
DIH
Sun Java
Aoyang Health
PKUCare Rehabilitation Hospital
Beijing Puhua International Hospital
Xiangyu Medical
Beijing United Family Rehabilitation Hospital
Neurorehabilitation Segment by Type
Brain Injury
Spinal Cord Injury
Peripheral Nerve Injury
Other
Neurorehabilitation Segment by Application
General Hospital
Rehabilitation Specialist Hospital
Community Rehabilitation Center
Neurorehabilitation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurorehabilitation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurorehabilitation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurorehabilitation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Neurorehabilitation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Brain Injury
- Spinal Cord Injury
- Peripheral Nerve Injury
- Other
Applications
- General Hospital
- Rehabilitation Specialist Hospital
- Community Rehabilitation Center
Companies covered
- VISHEE
- Beijing Bo'ai Hospital
- Beijing Rehabilitation Hospital of Capital Medical University
- NCC
- CHIEFTAIN
- Tongji Hospital
- Haobro Medical Device
- DIH
- Sun Java
- Aoyang Health
- PKUCare Rehabilitation Hospital
- Beijing Puhua International Hospital
- Xiangyu Medical
- Beijing United Family Rehabilitation Hospital
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Neurorehabilitation by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Brain Injury
- 2.2.3 Spinal Cord Injury
- 2.2.4 Peripheral Nerve Injury
- 2.2.5 Other
- 2.3 Neurorehabilitation by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 General Hospital
- 2.3.3 Rehabilitation Specialist Hospital
- 2.3.4 Community Rehabilitation Center
- 2.4 Assumptions and Limitations
3 Neurorehabilitation Breakdown Data by Type
- 3.1 Global Neurorehabilitation Historic Market Size by Type (2021-2026)
- 3.2 Global Neurorehabilitation Forecasted Market Size by Type (2027-2032)
4 Neurorehabilitation Breakdown Data by Application
- 4.1 Global Neurorehabilitation Historic Market Size by Application (2021-2026)
- 4.2 Global Neurorehabilitation Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Neurorehabilitation Market Perspective (2021-2032)
- 5.2 Global Neurorehabilitation Growth Trends by Region
- 5.2.1 Global Neurorehabilitation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Neurorehabilitation Historic Market Size by Region (2021-2026)
- 5.2.3 Neurorehabilitation Forecasted Market Size by Region (2027-2032)
- 5.3 Neurorehabilitation Market Dynamics
- 5.3.1 Neurorehabilitation Industry Trends
- 5.3.2 Neurorehabilitation Market Drivers
- 5.3.3 Neurorehabilitation Market Challenges
- 5.3.4 Neurorehabilitation Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Neurorehabilitation Players by Revenue
- 6.1.1 Global Top Neurorehabilitation Players by Revenue (2021-2026)
- 6.1.2 Global Neurorehabilitation Revenue Market Share by Players (2021-2026)
- 6.2 Global Neurorehabilitation Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Neurorehabilitation Head Office and Area Served
- 6.4 Global Neurorehabilitation Players, Product Type & Application
- 6.5 Global Neurorehabilitation Manufacturers Established Date
- 6.6 Global Neurorehabilitation Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Neurorehabilitation Market Size (2021-2032)
- 7.2 North America Neurorehabilitation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Neurorehabilitation Market Size by Country (2021-2026)
- 7.4 North America Neurorehabilitation Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Neurorehabilitation Market Size (2021-2032)
- 8.2 Europe Neurorehabilitation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Neurorehabilitation Market Size by Country (2021-2026)
- 8.4 Europe Neurorehabilitation Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Neurorehabilitation Market Size (2021-2032)
- 9.2 Asia-Pacific Neurorehabilitation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Neurorehabilitation Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Neurorehabilitation Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Neurorehabilitation Market Size (2021-2032)
- 10.2 South America Neurorehabilitation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Neurorehabilitation Market Size by Country (2021-2026)
- 10.4 South America Neurorehabilitation Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Neurorehabilitation Market Size (2021-2032)
- 11.2 Middle East & Africa Neurorehabilitation Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Neurorehabilitation Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Neurorehabilitation Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 VISHEE
- 12.1.1 VISHEE Company Information
- 12.1.2 VISHEE Business Overview
- 12.1.3 VISHEE Revenue in Neurorehabilitation Business (2021-2026)
- 12.1.4 VISHEE Neurorehabilitation Product Portfolio
- 12.1.5 VISHEE Recent Developments
- 12.2 Beijing Bo'ai Hospital
- 12.2.1 Beijing Bo'ai Hospital Company Information
- 12.2.2 Beijing Bo'ai Hospital Business Overview
- 12.2.3 Beijing Bo'ai Hospital Revenue in Neurorehabilitation Business (2021-2026)
- 12.2.4 Beijing Bo'ai Hospital Neurorehabilitation Product Portfolio
- 12.2.5 Beijing Bo'ai Hospital Recent Developments
- 12.3 Beijing Rehabilitation Hospital of Capital Medical University
- 12.3.1 Beijing Rehabilitation Hospital of Capital Medical University Company Information
- 12.3.2 Beijing Rehabilitation Hospital of Capital Medical University Business Overview
- 12.3.3 Beijing Rehabilitation Hospital of Capital Medical University Revenue in Neurorehabilitation Business (2021-2026)
- 12.3.4 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Product Portfolio
- 12.3.5 Beijing Rehabilitation Hospital of Capital Medical University Recent Developments
- 12.4 NCC
- 12.4.1 NCC Company Information
- 12.4.2 NCC Business Overview
- 12.4.3 NCC Revenue in Neurorehabilitation Business (2021-2026)
- 12.4.4 NCC Neurorehabilitation Product Portfolio
- 12.4.5 NCC Recent Developments
- 12.5 CHIEFTAIN
- 12.5.1 CHIEFTAIN Company Information
- 12.5.2 CHIEFTAIN Business Overview
- 12.5.3 CHIEFTAIN Revenue in Neurorehabilitation Business (2021-2026)
- 12.5.4 CHIEFTAIN Neurorehabilitation Product Portfolio
- 12.5.5 CHIEFTAIN Recent Developments
- 12.6 Tongji Hospital
- 12.6.1 Tongji Hospital Company Information
- 12.6.2 Tongji Hospital Business Overview
- 12.6.3 Tongji Hospital Revenue in Neurorehabilitation Business (2021-2026)
- 12.6.4 Tongji Hospital Neurorehabilitation Product Portfolio
- 12.6.5 Tongji Hospital Recent Developments
- 12.7 Haobro Medical Device
- 12.7.1 Haobro Medical Device Company Information
- 12.7.2 Haobro Medical Device Business Overview
- 12.7.3 Haobro Medical Device Revenue in Neurorehabilitation Business (2021-2026)
- 12.7.4 Haobro Medical Device Neurorehabilitation Product Portfolio
- 12.7.5 Haobro Medical Device Recent Developments
- 12.8 DIH
- 12.8.1 DIH Company Information
- 12.8.2 DIH Business Overview
- 12.8.3 DIH Revenue in Neurorehabilitation Business (2021-2026)
- 12.8.4 DIH Neurorehabilitation Product Portfolio
- 12.8.5 DIH Recent Developments
- 12.9 Sun Java
- 12.9.1 Sun Java Company Information
- 12.9.2 Sun Java Business Overview
- 12.9.3 Sun Java Revenue in Neurorehabilitation Business (2021-2026)
- 12.9.4 Sun Java Neurorehabilitation Product Portfolio
- 12.9.5 Sun Java Recent Developments
- 12.10 Aoyang Health
- 12.10.1 Aoyang Health Company Information
- 12.10.2 Aoyang Health Business Overview
- 12.10.3 Aoyang Health Revenue in Neurorehabilitation Business (2021-2026)
- 12.10.4 Aoyang Health Neurorehabilitation Product Portfolio
- 12.10.5 Aoyang Health Recent Developments
- 12.11 PKUCare Rehabilitation Hospital
- 12.11.1 PKUCare Rehabilitation Hospital Company Information
- 12.11.2 PKUCare Rehabilitation Hospital Business Overview
- 12.11.3 PKUCare Rehabilitation Hospital Revenue in Neurorehabilitation Business (2021-2026)
- 12.11.4 PKUCare Rehabilitation Hospital Neurorehabilitation Product Portfolio
- 12.11.5 PKUCare Rehabilitation Hospital Recent Developments
- 12.12 Beijing Puhua International Hospital
- 12.12.1 Beijing Puhua International Hospital Company Information
- 12.12.2 Beijing Puhua International Hospital Business Overview
- 12.12.3 Beijing Puhua International Hospital Revenue in Neurorehabilitation Business (2021-2026)
- 12.12.4 Beijing Puhua International Hospital Neurorehabilitation Product Portfolio
- 12.12.5 Beijing Puhua International Hospital Recent Developments
- 12.13 Xiangyu Medical
- 12.13.1 Xiangyu Medical Company Information
- 12.13.2 Xiangyu Medical Business Overview
- 12.13.3 Xiangyu Medical Revenue in Neurorehabilitation Business (2021-2026)
- 12.13.4 Xiangyu Medical Neurorehabilitation Product Portfolio
- 12.13.5 Xiangyu Medical Recent Developments
- 12.14 Beijing United Family Rehabilitation Hospital
- 12.14.1 Beijing United Family Rehabilitation Hospital Company Information
- 12.14.2 Beijing United Family Rehabilitation Hospital Business Overview
- 12.14.3 Beijing United Family Rehabilitation Hospital Revenue in Neurorehabilitation Business (2021-2026)
- 12.14.4 Beijing United Family Rehabilitation Hospital Neurorehabilitation Product Portfolio
- 12.14.5 Beijing United Family Rehabilitation Hospital Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst